Updated Jul 16, 2026
Bunnage Mark E. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.00M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale | 33 | $453.45 | $15K |
| 2026-02-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 620 | $486.35 | $302K |
| 2026-02-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture [10b5-1] | 582 | $485.11 | $282K |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 1.2K | $473.68 | $560K |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 2.4K | $489.46 | $1.19M |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture [10b5-1] | 1.1K | $483.75 | $537K |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award [10b5-1] | 2.6K | $0.00 | |
| 2026-02-18 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 2.3K | $487.76 | $1.11M |
| 2026-02-12 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 2.0K | $460.43 | $931K |
| 2026-02-12 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture [10b5-1] | 1.1K | $468.41 | $528K |
Bunnage Mark E. is a corporate insider — currently tracked as EVP, Chief Scientific Officer of VERTEX PHARMACEUTICALS INC / MA (VRTX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($3.00M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bunnage Mark E. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.